Association between concurrent use of diltiazem and DOACs and risk of bleeding in atrial fibrillation patients. Shurrab M, Jackevicius CA, Austin PC, Tu K, et al. J Interv Card Electrophysiol 2022 Sep 23. pii: 10.1007/s10840-022-01355.

Read + Share

Amedeo Smart

Independent Medical Education

Shurrab M, Jackevicius CA, Austin PC, Tu K, et al. Association between concurrent use of diltiazem and DOACs and risk of bleeding in atrial fibrillation patients. J Interv Card Electrophysiol 2022 Sep 23. pii: 10.1007/s10840-022-01355.
PMID: 36149579